![](/img/cover-not-exists.png)
Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory “Prodrug”
Mendelsohn, Andrew R., Larrick, James W.Volume:
19
Language:
english
Journal:
Rejuvenation Research
DOI:
10.1089/rej.2016.1849
Date:
June, 2016
File:
PDF, 75 KB
english, 2016